Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Ketamine petition receives over 3,000 signatures
Stray dog
Ketamine is critical for control of zoonotic diseases like rabies.
Proposal to reschedule drug to be considered this week 

A WSAVA petition calling for ketamine not to be placed under international control has received over 3,000 signatures.

In 2014, China proposed to reclassify the drug to Schedule 1 following widespread misconception that it is only a ‘recreational drug’.

Yet a review by the World Health Organisation (WHO) concluded that ketamine abuse does not pose a global public health threat, and that such control would limit access to those who most need it as a life-saving anaesthetic.

This week, delegates at the 29th UN Convention on Narcotic Drugs (CND) (14-22 March, Vienna) will meet to decide between the two opposite proposals.

In an open letter, the WSAVA urge the CND to follow the recommendations of the WHO. In it they write:

“The proposal for international control stems from the widespread misconception that it is only a 'recreational drug.' This is an inaccurate view and devalues the contribution that ketamine makes to to human and animal health. The WSAVA believes that it is an essential medicine.

“Ketamine is a remarkably safe anaesthetic which has been used worldwide for more than 50 years. It does not depress respiration or the circulation.  It can be used without oxygen, ventilators and electricity supply and support systems required for other anaesthetics.  

“These characteristics make it the only anaesthetic suitable for both medical and veterinary use in lower and middle income countries.”

As well as having particular value ‘in the field’ - for trauma, traffic and sporting injuries, ketamine is the most common and often only product for steralization initiatives. It also plays a huge role in feral cat/dog populations and is critical for control of zoonotic diseases like rabies.

The WSAVA conclude: “The WSAVA believes that medical and veterinary professionals should continue to have access to ketamine under the current scheduling controls and calls on concerned individuals to support our campaign to allow access to this essential medicine.”

To support the campaign and sign the petition visit: www.change.org.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.